Literature DB >> 25704951

Pathological tau disrupts ongoing network activity.

Noa Menkes-Caspi1, Hagar G Yamin1, Vered Kellner1, Tara L Spires-Jones2, Dana Cohen1, Edward A Stern3.   

Abstract

Pathological tau leads to dementia and neurodegeneration in tauopathies, including Alzheimer's disease. It has been shown to disrupt cellular and synaptic functions, yet its effects on the function of the intact neocortical network remain unknown. Using in vivo intracellular and extracellular recordings, we measured ongoing activity of neocortical pyramidal cells during various arousal states in the rTg4510 mouse model of tauopathy, prior to significant cell death, when only a fraction of the neurons show pathological tau. In transgenic mice, membrane potential oscillations are slower during slow-wave sleep and under anesthesia. Intracellular recordings revealed that these changes are due to longer Down states and state transitions of membrane potentials. Firing rates of transgenic neurons are reduced, and firing patterns within Up states are altered, with longer latencies and inter-spike intervals. By changing the activity patterns of a subpopulation of affected neurons, pathological tau reduces the activity of the neocortical network.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25704951     DOI: 10.1016/j.neuron.2015.01.025

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  71 in total

Review 1.  [Mechanisms of Alzheimer's disease : Neuronal hyperactivity and hypoactivity as new therapeutic targets].

Authors:  M A Busche; M Staufenbiel; M Willem; C Haass; H Förstl
Journal:  Nervenarzt       Date:  2016-11       Impact factor: 1.214

2.  Neuronal Network Excitability in Alzheimer's Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau.

Authors:  Syed Faraz Kazim; Joon Ho Seo; Riccardo Bianchi; Chloe S Larson; Abhijeet Sharma; Robert K S Wong; Kirill Y Gorbachev; Ana C Pereira
Journal:  eNeuro       Date:  2021-04-23

3.  Cortex-wide BOLD fMRI activity reflects locally-recorded slow oscillation-associated calcium waves.

Authors:  Miriam Schwalm; Florian Schmid; Lydia Wachsmuth; Cornelius Faber; Albrecht Stroh; Hendrik Backhaus; Andrea Kronfeld; Felipe Aedo Jury; Pierre-Hugues Prouvot; Consuelo Fois; Franziska Albers; Timo van Alst
Journal:  Elife       Date:  2017-09-15       Impact factor: 8.140

4.  Amyloid-β induces sleep fragmentation that is rescued by fatty acid binding proteins in Drosophila.

Authors:  Jason R Gerstner; Olivia Lenz; William M Vanderheyden; May T Chan; Cory Pfeiffenberger; Allan I Pack
Journal:  J Neurosci Res       Date:  2016-06-19       Impact factor: 4.164

Review 5.  Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease?

Authors:  Bryce A Mander; Joseph R Winer; William J Jagust; Matthew P Walker
Journal:  Trends Neurosci       Date:  2016-06-17       Impact factor: 13.837

6.  Neurophysiological signatures in Alzheimer's disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline.

Authors:  Kamalini G Ranasinghe; Jungho Cha; Leonardo Iaccarino; Leighton B Hinkley; Alexander J Beagle; Julie Pham; William J Jagust; Bruce L Miller; Katherine P Rankin; Gil D Rabinovici; Keith A Vossel; Srikantan S Nagarajan
Journal:  Sci Transl Med       Date:  2020-03-11       Impact factor: 17.956

7.  Sleep as a Potential Biomarker of Tau and β-Amyloid Burden in the Human Brain.

Authors:  Joseph R Winer; Bryce A Mander; Randolph F Helfrich; Anne Maass; Theresa M Harrison; Suzanne L Baker; Robert T Knight; William J Jagust; Matthew P Walker
Journal:  J Neurosci       Date:  2019-06-17       Impact factor: 6.167

8.  Maturation and phenotype of pathophysiological neuronal excitability of human cells in tau-related dementia.

Authors:  Olga Kopach; Noemí Esteras; Selina Wray; Dmitri A Rusakov; Andrey Y Abramov
Journal:  J Cell Sci       Date:  2020-05-27       Impact factor: 5.285

9.  Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.

Authors:  Masafumi Shimojo; Hiroyuki Takuwa; Yuhei Takado; Masaki Tokunaga; Satoshi Tsukamoto; Keiichiro Minatohara; Maiko Ono; Chie Seki; Jun Maeda; Takuya Urushihata; Takeharu Minamihisamatsu; Ichio Aoki; Kazunori Kawamura; Ming-Rong Zhang; Tetsuya Suhara; Naruhiko Sahara; Makoto Higuchi
Journal:  J Neurosci       Date:  2020-04-07       Impact factor: 6.167

10.  Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280.

Authors:  Frank J A Dennissen; Marta Anglada-Huguet; Astrid Sydow; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.